Home › Asset managers › Compare 2024-2025 › BlackRock vs Invesco
BlackRock 2024-2025 · Invesco 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 11,793 | 10,512 | 892 | 389 | 92.2% | 91.0% |
| Board proposals | 9,294 | 8,271 | 763 | 260 | 91.6% | 90.5% |
| E&S shareholder proposals | 236 | 187 | 7 | 42 | 96.4% | 93.6% |
| Other items | 2,263 | 2,054 | 122 | 87 | 94.4% | 92.3% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
763 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | BlackRock | Invesco |
|---|---|---|---|---|---|---|
| UIPATH INC. | June 26, 2025 | To approve, on a non-binding, advisory basis, the compensation paid to our named executive officers ("say-on-pay vote"). Say-on-Pay |
Board | For | FOR 36 funds |
AGAINST 5 funds |
| UMICORE SA | April 24, 2025 | Elect Michael Bredael as Member of the Supervisory Board Director Elections |
Board | For | FOR 10 funds |
AGAINST 1 fund |
| UNICREDIT SPA | March 27, 2025 | APPROVE REMUNERATION POLICY Say-on-Pay |
Board | For | FOR 54 funds |
AGAINST 2 funds |
| UNICREDIT SPA | March 27, 2025 | APPROVE SECOND SECTION OF THE REMUNERATION REPORT Say-on-Pay |
Board | For | FOR 54 funds |
AGAINST 2 funds |
| UNIFIRST CORP. | January 14, 2025 | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers as more fully described in the accompanying Proxy Statement. Say-on-Pay |
Board | For | FOR 28 funds |
AGAINST 6 funds |
| UNIQURE N.V. | June 11, 2025 | Reappointment of Jeremy Springhorn, Ph.D. as non-executive director. Director Elections |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| UNISYS CORP. | May 8, 2025 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 16 funds |
AGAINST 3 funds |
| UNITED STATES STEEL CORP. | May 6, 2025 | To consider and act on a non-binding advisory vote regarding the approval of compensation paid to certain executive officers. Say-on-Pay |
Board | Contested | FOR 50 funds |
AGAINST 7 funds |
| UNIVERSAL LOGISTICS HOLDINGS INC. | April 23, 2025 | To approve the conversion of the Company to a Nevada corporation. Extraordinary Transactions |
Board | For | AGAINST 10 funds |
FOR 1 fund |
| UPSTART HOLDINGS INC. | May 23, 2025 | The approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 28 funds |
AGAINST 7 funds |
| UROGEN PHARMA LTD | August 6, 2024 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting. Say-on-Pay |
Board | For | FOR 12 funds |
AGAINST 2 funds |
| V.F. CORP. | July 23, 2024 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 35 funds |
AGAINST 8 funds |
| VALHI INC. | May 22, 2025 | Nonbinding advisory vote approving named executive officer compensation. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 2 funds |
| VALVOLINE INC. | January 28, 2025 | Non-binding Advisory Resolution Approving our Executive Compensation. Say-on-Pay |
Board | For | FOR 35 funds |
AGAINST 14 funds |
| VAXART INC. | June 13, 2025 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| VENTYX BIOSCIENCES INC. | June 4, 2025 | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement (the "Say-on-Pay Vote"). Say-on-Pay |
Board | For | FOR 11 funds |
AGAINST 3 funds |
| VERA THERAPEUTICS INC. | May 14, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 25 funds |
AGAINST 3 funds |
| VERASTEM INC. | May 22, 2025 | To approve an advisory vote on the compensation of the named executive officers. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 3 funds |
| VERBUND AG | April 29, 2025 | REELECT ROBERT STAJIC AS SUPERVISORY BOARD MEMBER Director Elections |
Board | For | FOR 31 funds |
AGAINST 3 funds |
| VERICEL CORP. | April 30, 2025 | To approve, on an advisory basis, the compensation of Vericel Corporation's named executive officers. Say-on-Pay |
Board | For | FOR 30 funds |
AGAINST 15 funds |
| VERONA PHARMA PLC | April 24, 2025 | To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| VERRICA PHARMACEUTICALS INC. | June 5, 2025 | Approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| VERVE THERAPEUTICS INC. | June 5, 2025 | Approval, on an advisory basis, of the compensation paid to our named executive officers. Say-on-Pay |
Board | For | FOR 25 funds |
AGAINST 4 funds |
| VICTORY CAPITAL HOLDINGS INC. | October 11, 2024 | To amend Victory Capital's Second Amended and Restated Certificate of Incorporation to increase its authorized number of shares of preferred stock, par value $0.01 per share, to 100,000,000 (the "authorized preferred share increase proposal"). Capital Structure |
Board | For | FOR 16 funds |
AGAINST 4 funds |
| VICTORY CAPITAL HOLDINGS INC. | May 7, 2025 | A non-binding advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 28 funds |
AGAINST 6 funds |
| VIKING HOLDINGS LTD | May 15, 2025 | Election of Director: Torstein Hagen Director Elections |
Board | For | FOR 3 funds |
AGAINST 4 funds |
| VIKING THERAPEUTICS INC | May 20, 2025 | TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. Say-on-Pay |
Board | For | FOR 38 funds |
AGAINST 4 funds |
| VIPER ENERGY INC. | May 20, 2025 | The approval, on an advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 43 funds |
AGAINST 3 funds |
| VIRGIN GALACTIC HOLDINGS INC. | June 5, 2025 | Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 10 funds |
AGAINST 3 funds |
| VIRIDIAN THERAPEUTICS INC. | June 20, 2025 | To approve a further amendment and restatement of the Company's Amended and Restated 2016 Equity Incentive Plan, including increasing the number of shares available for issuance thereunder by 8,000,000 shares. Compensation |
Board | For | FOR 14 funds |
AGAINST 1 fund |
| VIRIDIAN THERAPEUTICS INC. | June 20, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 25 funds |
AGAINST 4 funds |
| VOLVO AB | April 2, 2025 | ELECT CHAIR OF THE BOARD AS MEMBER OF NOMINATING COMMITTEE Corporate Governance |
Board | For | FOR 25 funds |
AGAINST 1 fund |
| VOLVO AB | April 2, 2025 | REELECT HELENA STJERNHOLM AS DIRECTOR Director Elections |
Board | For | FOR 25 funds |
AGAINST 1 fund |
| VOLVO AB | April 2, 2025 | REELECT PAR BOMAN AS DIRECTOR Director Elections |
Board | For | FOR 25 funds |
AGAINST 1 fund |
| VOYAGER THERAPEUTICS INC. | June 3, 2025 | To approve the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan. Compensation |
Board | For | FOR 17 funds |
AGAINST 1 fund |
| VOYAGER THERAPEUTICS INC. | June 3, 2025 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 24 funds |
AGAINST 3 funds |
| VUZIX CORP. | June 17, 2025 | To conduct a non-binding advisory vote on the compensation disclosed in the Proxy Statement of the Company's executive officers who are named in the Proxy Statement Summary Compensation Table. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| WAERTSILAE CORP. | March 13, 2025 | REELECT KAREN BOMBA, MORTEN H. ENGELSTOFT, KARIN FALK, JOHAN FORSSELL, TOM JOHNSTONE (CHAIR), TIINA TUOMELA AND MIKA VEHVILAINEN (VICE-CHAIR) AS DIRECTORS; ELECT HENRIK EHRNROOTH AS NEW DIRECTOR Director Elections |
Board | For | AGAINST 27 funds |
FOR 3 funds |
| WAFD INC. | February 11, 2025 | ADVISORY VOTE ON THE COMPENSATION OF WAFD, INC.'S NAMED EXECUTIVE OFFICERS. Say-on-Pay |
Board | For | FOR 27 funds |
AGAINST 7 funds |
| WARNER BROS. DISCOVERY INC. | June 2, 2025 | To vote on an advisory resolution to approve the 2024 compensation of Warner Bros. Discovery, Inc.'s named executive officers, commonly referred to as a "Say-on-Pay" vote. Say-on-Pay |
Board | For | FOR 60 funds |
AGAINST 27 funds |
| WASHINGTON TRUST BANCORP INC. | April 22, 2025 | A non-binding advisory resolution to approve the compensation of the Corporation's named executive officers. Say-on-Pay |
Board | For | FOR 25 funds |
AGAINST 6 funds |
| WATERS CORP. | May 22, 2025 | To approve, on a non-binding, advisory basis, the compensation of the Company's executive officers. Say-on-Pay |
Board | For | FOR 71 funds |
AGAINST 20 funds |
| WAVE LIFE SCIENCES LTD. | August 6, 2024 | To approve, by a non-binding advisory vote, the compensation of our named executive officers as disclosed in the proxy statement Say-on-Pay |
Board | For | FOR 16 funds |
AGAINST 3 funds |
| WESBANCO INC. | April 16, 2025 | To approve an advisory (non-binding) vote on compensation paid to Wesbanco's named executive officers. Say-on-Pay |
Board | For | FOR 25 funds |
AGAINST 7 funds |
| WESCO INTE | May 22, 2025 | Approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | Not determined | FOR 42 funds |
AGAINST 15 funds |
| WESTERN DIGITAL CORP. | November 20, 2024 | Approval on an advisory basis of the named executive officer compensation disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 61 funds |
AGAINST 19 funds |
| WIDEOPENWEST INC. | May 8, 2025 | Approve, by non-binding advisory vote, the Company's executive compensation. Say-on-Pay |
Board | For | FOR 12 funds |
AGAINST 3 funds |
| WIHLBORGS FASTIGHETER AB | April 29, 2025 | REELECT JAN LITBORN AS DIRECTOR Director Elections |
Board | For | FOR 10 funds |
AGAINST 2 funds |
| WIHLBORGS FASTIGHETER AB | April 29, 2025 | REELECT LENNART MAURITZON AS DIRECTOR Director Elections |
Board | For | FOR 10 funds |
AGAINST 2 funds |
| WINMARK CORP. | April 23, 2025 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 23 funds |
AGAINST 7 funds |
| WK KELLOGG CO | May 1, 2025 | A non-binding advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 26 funds |
AGAINST 7 funds |
| WOODWARD INC. | January 29, 2025 | Vote on an advisory resolution regarding the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 39 funds |
AGAINST 6 funds |
| WORKDAY INC. | June 4, 2025 | To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 64 funds |
AGAINST 23 funds |
| WORTHINGTON ENTERPRISES INC. | September 24, 2024 | Approve, on an advisory basis, a resolution to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 30 funds |
AGAINST 10 funds |
| WORTHINGTON STEEL INC | September 25, 2024 | Approve, on an advisory basis, a resolution to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 28 funds |
AGAINST 5 funds |
| X4 PHARMACEUTICALS INC. | June 9, 2025 | To hold a non-binding, advisory "say-on-pay" vote on the Company's executive compensation. Say-on-Pay |
Board | For | FOR 10 funds |
AGAINST 2 funds |
| XENCOR INC. | June 12, 2025 | To approve the proposed amendment and restatement of the Company's 2023 Equity Incentive Plan to increase the number of authorized shares reserved for issuance thereunder by 3,000,000 shares. Compensation |
Board | For | FOR 20 funds |
AGAINST 3 funds |
| XENCOR INC. | June 12, 2025 | To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers, as disclosed in the accompanying Proxy Statement. Say-on-Pay |
Board | For | FOR 33 funds |
AGAINST 6 funds |
| XERIS BIOPHARMA HOLDINGS INC. | June 4, 2025 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 17 funds |
AGAINST 3 funds |
| ZALANDO SE | May 27, 2025 | ELECT NIKLAS OESTBERG TO THE SUPERVISORY BOARD Director Elections |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| ZIPRECRUITER INC. | June 10, 2025 | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers. Say-on-Pay |
Board | For | FOR 27 funds |
AGAINST 4 funds |
| ZSCALER INC. | January 10, 2025 | To approve on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 60 funds |
AGAINST 11 funds |
| ZURN ELKAY | May 1, 2025 | Advisory vote to approve the compensation of Zurn Elkay's named executive officers, as disclosed in "Compensation Discussion and Analysis" and "Executive Compensation" in the Proxy Statement. Say-on-Pay |
Board | Not determined | FOR 35 funds |
AGAINST 12 funds |
← Previous Page 8 of 8
How items are matched and positions counted: see the comparison table and the methodology. Built October 25, 2026 from SEC Form N-PX filings.